Clinical trial
Irofulven in AR-targeted and Docetaxel-Pretreated mCRPC Patients With Drug Response Predictor (DRP®)
NCT03643107
Study timeline
Study start (actual)2018-10-17Date precision: day
Registry last updated2025-01-23
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Interventions
IrofulvenDRUG
Prednisolone 10 mgCOMBINATION_PRODUCT
Sponsors & collaborators
Allarity Therapeuticslead sponsor
Smerud Medical Research International AScollaborator
Lantern Pharma Inc.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03643107 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.